Budget Impact Fundamental

Brogan Inc's Pharmacoeconomic /Budget Impact Analysis Fundamental seminar is held annually in October.

This seminar offers a great learning opportunity for individuals who wish to further enhance their knowledge of preparing a Pharmacoeconomic (PE) or Budget Impact Analysis (BIA) and other economic information required for drug plan submissions and the Common Drug Review (CDR) Process.

Economic information, pharmacoeconomic and budget impact analyses, are a mandatory part of drug plan submissions. A high-quality assessment that anticipates questions and challenges can make the difference between quick market access and costly delays and rejections. The Brogan Inc.'s Health Economics Group has consistently been on the cutting edge of this ever-changing environment.

Come to this day-long workshop and presentation and learn the necessary requirements, techniques, and processes for preparing high-quality and complete economic evidence for drug plan submissions. In addition to drug plan submissions, PE and budget impact analyses are also helpful for hospital products where economic arguments based on budget impact and pharmacoeconomics could significantly improve the likelihood of hospital listing and reimbursement.


Outline

Everything you wanted to learn about preparing Pharmacoeconomic and Budget Impact reports!

Topics covered include:

 » Market Access Overview:
   · Historic Overview
   · New Direction (CDR)
   · Exceptions
     ° Compare provinces
 » Provincial Review Process
   · Who does it?
     ° What are they looking for?
 » Pharmacoeconomic Preparation
   · What is an economic evaluation?
   · What is a good comparator for PE evaluation?
   · What are the best sources of data?
   · When should one consider a cost-utility over a cost-effectiveness analysis?
   · Simple decision analysis using TreeAge DATA Pro software
   · Original Canadian versus Canadian adaptation of economic evaluation
   · Deterministic versus probabilistic sensitivity analysis
 » Budget Impact Preparation
   · Data sources & other inputs
   · Calculations and analysis
   · Sensitivity analysis
 » Outputs/Presentation
   · Report / briefing notes
   · Templates
 » Product Listing Agreement Trends
 » How Brogan Inc. helps you achieve you goals


Why should you attend?

For a solid understanding of the PE/BIA Fundamentals, it is best to learn it directly from the experts!

Brogan Inc. has been consulting with the pharmaceutical industry on PE/BIA for over 15 years.


Who should attend?

The seminar is useful to anyone involved in formulary submissions, including:

• Government Affairs Managers
• Product Managers
• New Product Development Managers
• Health Policy Specialists
• Health Economics and Health Outcomes Managers
• Private Drug Plan Reimbursement Managers